Glaukos Corp (GKOS)
107.18
+2.17
(+2.07%)
USD |
NYSE |
May 07, 10:40
Glaukos Cash from Investing (TTM): -1.456M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -1.456M |
December 31, 2023 | 14.10M |
September 30, 2023 | 43.67M |
June 30, 2023 | 53.16M |
March 31, 2023 | 36.84M |
December 31, 2022 | 44.78M |
September 30, 2022 | 19.25M |
June 30, 2022 | -31.20M |
March 31, 2022 | -42.87M |
December 31, 2021 | -58.23M |
September 30, 2021 | -52.82M |
June 30, 2021 | -208.32M |
March 31, 2021 | -226.95M |
December 31, 2020 | -205.06M |
September 30, 2020 | -151.79M |
June 30, 2020 | 25.70M |
March 31, 2020 | 45.77M |
December 31, 2019 | 43.43M |
September 30, 2019 | -24.14M |
Date | Value |
---|---|
June 30, 2019 | -26.00M |
March 31, 2019 | -22.86M |
December 31, 2018 | -26.40M |
September 30, 2018 | -16.34M |
June 30, 2018 | -11.85M |
March 31, 2018 | -15.54M |
December 31, 2017 | -12.39M |
September 30, 2017 | -7.558M |
June 30, 2017 | -16.28M |
March 31, 2017 | -19.73M |
December 31, 2016 | -26.12M |
September 30, 2016 | -93.38M |
June 30, 2016 | -83.40M |
March 31, 2016 | -93.90M |
December 31, 2015 | -85.63M |
September 30, 2015 | -15.79M |
June 30, 2015 | -15.88M |
March 31, 2015 | -0.894M |
December 31, 2014 | -0.868M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-226.95M
Minimum
Mar 2021
53.16M
Maximum
Jun 2023
-35.11M
Average
-12.80M
Median
Cash from Investing (TTM) Benchmarks
Boston Scientific Corp | -2.375B |
Globus Medical Inc | 302.97M |
PROCEPT BioRobotics Corp | -21.81M |
Accuray Inc | -12.22M |
Asensus Surgical Inc | 64.51M |